Shanghai MicroPort MedBot Group Co Ltd (2252:HK) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Shanghai MicroPort MedBot Group Co Ltd stock forecast from 0 analysts, the average analyst target price for Shanghai MicroPort MedBot Group Co Ltd is not available over the next 12 months. Shanghai MicroPort MedBot Group Co Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Shanghai MicroPort MedBot Group Co Ltd is Slightly Bearish, which is based on 3 positive signals and 7 negative signals. At the last closing, Shanghai MicroPort MedBot Group Co Ltd’s stock price was HKD 11.82. Shanghai MicroPort MedBot Group Co Ltd’s stock price has changed by -6.49% over the past week, -19.04% over the past month and -55.23% over the last year.
No recent analyst target price found for Shanghai MicroPort MedBot Group Co Ltd
No recent average analyst rating found for Shanghai MicroPort MedBot Group Co Ltd
Company Overview Shanghai MicroPort MedBot Group Co Ltd
Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People's Republic of China. It offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; SkyWalker, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot for coronary angioplasty; and iSR'obot, a Mona Lisa robotic transperineal prostate biopsy system. The company also provides spine surgical robots for spine surgery; trans-bronchial surgical robots for trans-bronchial diagnosis and treatment; TAVR surgical robots for heart valve replacement surgery; and thoracic and abdominal puncture surgical robot for percutaneous lung biopsy and percutaneous liver biopsy. In addition, it manufactures parts of surgical robot devices; engages in assembly and distribution of surgical robot devices; research and development of system, as well as investment activities. Shanghai MicroPort MedBot (Group) Co., Ltd. was founded in 2014 and is based in Shanghai, China. Shanghai MicroPort MedBot (Group) Co., Ltd. operates as a subsidiary of Shanghai Latent Artificial Intelligence Co., Ltd. Read Less
Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People's Republic of China. It offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeri...Read More
Frequently Asked Questions About Shanghai MicroPort MedBot Group Co Ltd (2252:HK) Stock
Stock Target Advisor's fundamental analysis for Shanghai MicroPort MedBot Group Co Ltd's stock is Slightly Bearish.
Unfortunately we do not have enough data on 2252:HK's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 2252:HK's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 2252:HK's stock to indicate if its overvalued.
The last closing price of 2252:HK's stock was HKD 11.82.
The most recent market capitalization for 2252:HK is HKD 12.20B.
Unfortunately we do not have enough analyst data on 2252:HK's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Shanghai MicroPort MedBot Group Co Ltd's stock.
As per our most recent records Shanghai MicroPort MedBot Group Co Ltd has 900 Employees.
Shanghai MicroPort MedBot Group Co Ltd's registered address is Building 1, Shanghai, China.
You can get more information about it from Shanghai MicroPort MedBot Group Co Ltd's website at https://www.medbotsurgical.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 2252:HK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
